Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer

Journal of Otolaryngology

Volumn 33, Issue 6, 2004, Pages 339-344

  Waseem, Zeeshan ^a   Palme, Carsten E ^a   Walfish, Paul ^a   Freeman, Jeremy L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Recurrence; Site of recurrence; Well differentiated thyroid cancer

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SURVIVAL RATE; THYROID CARCINOMA; TREATMENT FAILURE; TUMOR DIFFERENTIATION;

EID: 15444362696     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2004.04013     Document Type: Article

References (27)

1. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315-32.
2. Mazzaferri E, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
3. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-20.
4. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7.
5. Samaan NA, Maheswari YK, Nader S, et al. Impact of therapy for differentiated thyroid carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-8.
6. Tubiana M, Schlumberger M, Rougier P, et al. Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
7. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 19 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
8. Hirabayashi RN, Lindsay S. Carcinoma of the thyroid gland: a statistical study of 390 patients. J Clin Endocrinol Metab 1961;21:1596-1610.
9. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978-96.
10. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104:954-62.
11. Schroder DM, Chambers A, France CJ. Operative strategy for thyroid cancer: is total thyroidectomy worth the price? Cancer 1986;58:2320-8.
12. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24.
13. Simpson WJ, McKinney S, Carruthers JS, et al. Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am J Med 1987;83:479-88.
14. Harness JK, McLeod MK, Thompson NW, et al. Deaths due to differentiated thyroid cancer: a 46-year perspective. World J Surg 1988;12:623-9.
15. Beenken S, Guillamondegui O, Shallenberger R, et al. Prognostic factors in patients dying of well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 1989;102:51-5.
16. Clark OH. Recurrent thyroid cancer. J Endocrinol Invest 1995;18:167-9.
17. Beasley NJ, Lee J, Eski S, et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 2002;128:825-8.
18. Stojadinovic A, Shoup M, Nissan A, et al. Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence. Ann Surg Oncol 2002;9:789-98.
19. McCaffrey TV, Bergstralh EJ, Hay ID. Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck 1994;16: 165-72.
20. Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860-6.
21. 131). Ann Surg 1994;219:587-95.
22. Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well differentiated thyroid malignancy. Surgery 2001;130:971-7.
23. Stojadinovic A, Shoup M, Ghossein R, et al. The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery 2002;131:636-43.
24. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605.
25. Eustatia-Rutten CFA, Rominjn A, Guijt HJ, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88: 3184-9.
26. Haugen BR. Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol 1999; 16:34-41.
27. Pineda JD, Lee T, Ain K, et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995;80:1488-92.